![1]()
News
As new cases fall, U.S. passes 4 million children with COVID-19
June 15, 2021
CDC data suggest that vaccination has already slowed among children aged 12-15 years.
News
Simple risk assessment predicts post-PCI ischemic events
June 15, 2021
Determining if PCI patients have just one or more guideline-based risk features predicts their odds of ischemic events, and can be used to tailor antiplatelet therapy, suggests a real-world analysis.
News
OSHA issues new rules on COVID-19 safety for health care workers
June 14, 2021
“The science tells us that health care workers, particularly those who come into regular contact with the virus, are most at risk at this point in the pandemic.”
![1]()
News
Infections in infants: An update
June 14, 2021
Among newer tests developed, a negative procalcitonin has the highest negative predictive value.
News
Are left atrial thrombi that defy preprocedure anticoagulation predictable?
June 11, 2021
Features that predispose to such persistent LA thrombi, which are not very rare, could potentially guide more targeted TEE screening before rhythm-control procedures.
News
First risk score to predict bleeding risk after TAVR
June 11, 2021
PREDICT-TAVR was developed and validated in two national registries in Europe and outperformed existing risk scores developed outside TAVR.
![1]()
News
Early high-dose vitamin D3 did not reduce mortality in critically ill, vitamin D–deficient patients
June 11, 2021
Does early administration of high-dose vitamin D3 in critically ill, vitamin D–deficient patients reduce 90-day all-cause mortality?
![1]()
News
Mavrilimumab may aid severe COVID-19 recovery
June 10, 2021
The granulocyte/macrophage-colony stimulating factor (GM-CSF) blocker reduced the need for mechanical ventilation and death by day 29 versus placebo.
![1]()
News
Hospital-level care at home for acutely ill adults may be as safe as inpatient care
June 10, 2021
Does hospital-level care at home reduce health care cost, usage, and readmission rates?
![1]()
News
For patients with advanced CKD, low risk of nephrogenic systemic fibrosis with group II GBCAs
June 9, 2021
What is the risk of nephrogenic systemic fibrosis (NSF) with use of group II gadolinium-based contrast agents (GBCAs) in patients with chronic kidney disease (CKD) stages IV and V?
